Serum cytokine analysis in a positive chemoprevention trial: selenium, interleukin-2, and an association with squamous preneoplastic disease.

Roth, Mark J; Katki, Hormuzd A; Wei, Wen-Qiang; Qiao, You-Lin; Bagni, Rachel; Wang, Guo-Qing; Whitby, Denise; Dong, Zhi-Wei; Gail, Mitchell H; Limburg, Paul J; Giffen, Carol A; Taylor, Philip R; Dawsey, Sanford M

Roth, Mark J; Katki, Hormuzd A; Wei, Wen-Qiang; Qiao, You-Lin; Bagni, Rachel; Wang, Guo-Qing; Whitby, Denise; Dong, Zhi-Wei; Gail, Mitchell H; Limburg, Paul J; Giffen, Carol A; Taylor, Philip R; Dawsey, Sanford M.

Affiliation

Roth MJ; Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892-7232, USA. mr166i@nih.gov

Cancer Prev Res (Phila) ; 3(7): 810-7, 2010 Jul.

Article in En | MEDLINE | ID: mdl-20587703

Subject(s)

Anticarcinogenic Agents/therapeutic use; Cytokines/blood; Esophageal Neoplasms/blood; Interleukin-2/blood; Neoplasms, Squamous Cell/blood; Precancerous Conditions/blood; Selenomethionine/therapeutic use; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Celecoxib; Esophageal Neoplasms/prevention & control; Female; Humans; Male; Middle Aged; Neoplasms, Squamous Cell/prevention & control; Odds Ratio; Precancerous Conditions/drug therapy; Pyrazoles/therapeutic use; Sulfonamides/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Precancerous Conditions / Selenomethionine / Esophageal Neoplasms / Cytokines / Interleukin-2 / Anticarcinogenic Agents / Neoplasms, Squamous Cell Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Language: En Journal: Cancer Prev Res (Phila) Year: 2010 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google